The drug maker on 26 September 2020 announced the launch of Fevindo (Favipiravir) 400 mg tablets in Indi
Fevindo-400 will be made available at all government approved COVID care centres and selected medical practitioners
across the country.
The company’s consolidated net profit jumped 821.10% to Rs 17.04 crore on a 7.9% increase in net sales to Rs 266.80
crore in Q1 June 2020 over Q1 June 2019.
